• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

体重指数与散发性甲状腺髓样癌:来自大量病例系列的见解

Body Mass Index and Sporadic Medullary Thyroid Cancer: Insights from a Large Series.

作者信息

Prete Alessandro, Gambale Carla, Bottici Valeria, Cappagli Virginia, Aringhieri Giacomo, Puccini Marco, Landi Stefano, Torregrossa Liborio, Santini Ferruccio, Matrone Antonio, Elisei Rossella

机构信息

Unit of Endocrinology, Department of Clinical and Experimental Medicine, University of Pisa, 56124 Pisa, Italy.

Academic Radiology, Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, 56124 Pisa, Italy.

出版信息

Cancers (Basel). 2025 Mar 11;17(6):950. doi: 10.3390/cancers17060950.

DOI:10.3390/cancers17060950
PMID:40149286
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11940153/
Abstract

: Excess adipose tissue has been associated with the increased prevalence and aggressiveness of many human cancers. While its role in differentiated thyroid cancer is well established, in medullary thyroid cancer (MTC), data are conflicting. We aimed to evaluate the impact of excess adipose tissue on MTC prevalence, aggressiveness at diagnosis, and outcome in a large series of patients. : We evaluated 529 patients with sporadic MTC from a prospectively maintained database. Weight and height were measured in all patients at the time of surgery, and body mass index (BMI) was calculated. Therefore, patients were classified according to BMI categories suggested by the WHO for Caucasian patients. Data about somatic mutations were available in 254/529 patients (48.0%). : The prevalence of subjects with obesity was higher than that in the Italian general population (20.2 vs. 12.0%). Patients with obesity presented smaller tumors, lower T and N stage, and lower stage, as well as lower preoperative calcitonin values compared to under/normal and overweight ones. The prevalence of somatic and mutations did not differ significantly across the WHO BMI categories. At the end of follow-up, structural disease was less common in patients with obesity (15.4%) compared to under/normal (25.6%, < 0.05) and overweight (24.1%, = 0.079). Further surgeries for local recurrence were less common in patients with obesity (3.8%) compared to overweight ones (11.0%, < 0.05). Survival was superimposable in the different categories of BMI. : Among patients with sporadic MTC, there is a higher prevalence of patients with obesity compared to the general population. A higher BMI was associated with less aggressive clinical presentation and better clinical outcomes.

摘要

过多的脂肪组织与许多人类癌症的患病率增加和侵袭性增强有关。虽然其在分化型甲状腺癌中的作用已得到充分证实,但在髓样甲状腺癌(MTC)中,数据存在冲突。我们旨在评估过多的脂肪组织对大量患者中MTC患病率、诊断时的侵袭性及预后的影响。

我们从一个前瞻性维护的数据库中评估了529例散发性MTC患者。在所有患者手术时测量体重和身高,并计算体重指数(BMI)。因此,根据世界卫生组织针对白种人患者建议的BMI类别对患者进行分类。254/529例患者(48.0%)有体细胞突变数据。

肥胖患者的患病率高于意大利普通人群(20.2%对12.0%)。与体重过轻/正常和超重患者相比,肥胖患者的肿瘤较小、T和N分期较低、分期较低,术前降钙素值也较低。世界卫生组织BMI类别中体细胞 和 突变的患病率无显著差异。随访结束时,肥胖患者中结构性疾病的发生率(15.4%)低于体重过轻/正常患者(25.6%,<0.05)和超重患者(24.1%,=0.079)。肥胖患者局部复发的再次手术发生率(3.8%)低于超重患者(11.0%,<0.05)。不同BMI类别患者的生存率相近。

在散发性MTC患者中,肥胖患者的患病率高于普通人群。较高的BMI与侵袭性较低的临床表现和较好的临床结局相关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d6ef/11940153/52d41ed6e514/cancers-17-00950-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d6ef/11940153/e343de859bdd/cancers-17-00950-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d6ef/11940153/9e606511b5ec/cancers-17-00950-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d6ef/11940153/52d41ed6e514/cancers-17-00950-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d6ef/11940153/e343de859bdd/cancers-17-00950-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d6ef/11940153/9e606511b5ec/cancers-17-00950-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d6ef/11940153/52d41ed6e514/cancers-17-00950-g003.jpg

相似文献

1
Body Mass Index and Sporadic Medullary Thyroid Cancer: Insights from a Large Series.体重指数与散发性甲状腺髓样癌:来自大量病例系列的见解
Cancers (Basel). 2025 Mar 11;17(6):950. doi: 10.3390/cancers17060950.
2
Tumor Grade and Molecular Characteristics Associated with Survival in Sporadic Medullary Thyroid Carcinoma.散发性甲状腺髓样癌的肿瘤分级及与生存相关的分子特征
Thyroid. 2024 Feb;34(2):177-185. doi: 10.1089/thy.2023.0482. Epub 2023 Dec 27.
3
Prevalence and clinical spectrum of nonsecretory medullary thyroid carcinoma in a series of 839 patients with sporadic medullary thyroid carcinoma.839 例散发性甲状腺髓样癌患者中非分泌型甲状腺髓样癌的患病率及临床谱。
Thyroid. 2013 Mar;23(3):294-300. doi: 10.1089/thy.2012.0236. Epub 2013 Jan 11.
4
The prevalence of somatic RAS mutations in medullary thyroid cancer - a Polish population study.甲状腺髓样癌中体细胞RAS突变的患病率——一项波兰人群研究
Endokrynol Pol. 2015;66(2):121-5. doi: 10.5603/EP.2015.0018.
5
Prognostic significance of somatic RET oncogene mutations in sporadic medullary thyroid cancer: a 10-year follow-up study.散发性甲状腺髓样癌中体细胞RET癌基因突变的预后意义:一项10年随访研究
J Clin Endocrinol Metab. 2008 Mar;93(3):682-7. doi: 10.1210/jc.2007-1714. Epub 2007 Dec 11.
6
RAS proto-oncogene in medullary thyroid carcinoma.甲状腺髓样癌中的RAS原癌基因。
Endocr Relat Cancer. 2015 Oct;22(5):R235-52. doi: 10.1530/ERC-15-0070.
7
Medullary Thyroid Carcinoma: Survival Analysis and Evaluation of Mutation-Specific Immunohistochemistry in Detection of Sporadic Disease.髓样甲状腺癌:散发性疾病检测中生存分析及突变特异性免疫组化评估
World J Surg. 2018 May;42(5):1432-1439. doi: 10.1007/s00268-018-4551-8.
8
Evidence of a low prevalence of RAS mutations in a large medullary thyroid cancer series.大样本甲状腺髓样癌中 RAS 突变低发生率的证据。
Thyroid. 2013 Jan;23(1):50-7. doi: 10.1089/thy.2012.0207. Epub 2012 Dec 16.
9
High prevalence of RAS mutations in RET-negative sporadic medullary thyroid carcinomas.RET 阴性散发性甲状腺髓样癌中 RAS 突变的高发生率。
J Clin Endocrinol Metab. 2011 May;96(5):E863-8. doi: 10.1210/jc.2010-1921. Epub 2011 Feb 16.
10
Clinical utility of genetic diagnosis for sporadic and hereditary medullary thyroid carcinoma.遗传性和散发性甲状腺髓样癌的基因诊断的临床实用性。
Ann Endocrinol (Paris). 2019 Jun;80(3):187-190. doi: 10.1016/j.ando.2019.04.014. Epub 2019 Apr 11.

本文引用的文献

1
Obesity-dependent selection of driver mutations in cancer.肥胖相关的癌症驱动突变选择。
Nat Genet. 2024 Nov;56(11):2318-2321. doi: 10.1038/s41588-024-01969-3. Epub 2024 Oct 28.
2
New Horizons: Epidemiology of Obesity, Diabetes Mellitus, and Cancer Prognosis.新视野:肥胖症、糖尿病与癌症预后的流行病学
J Clin Endocrinol Metab. 2024 Mar 15;109(4):924-935. doi: 10.1210/clinem/dgad450.
3
Obesity-associated changes in molecular biology of primary breast cancer.肥胖相关的原发性乳腺癌分子生物学改变。
Nat Commun. 2023 Jul 21;14(1):4418. doi: 10.1038/s41467-023-39996-z.
4
Bioinformatic analysis of the obesity paradox and possible associated factors in colorectal cancer using TCGA cohorts.利用癌症基因组图谱(TCGA)队列对肥胖悖论及结直肠癌可能的相关因素进行生物信息学分析。
J Cancer. 2023 Jan 22;14(3):322-335. doi: 10.7150/jca.80977. eCollection 2023.
5
Clinical Evolution of Sporadic Medullary Thyroid Carcinoma With Biochemical Incomplete Response After Initial Treatment.初始治疗后生化未完全缓解的散发性甲状腺髓样癌的临床演变。
J Clin Endocrinol Metab. 2023 Jul 14;108(8):e613-e622. doi: 10.1210/clinem/dgad061.
6
Understanding the effect of obesity on papillary thyroid cancer: is there a need for tailored diagnostic and therapeutic management?了解肥胖对甲状腺乳头状癌的影响:是否需要针对性的诊断和治疗管理?
Expert Rev Endocrinol Metab. 2022 Nov;17(6):475-484. doi: 10.1080/17446651.2022.2131529. Epub 2022 Oct 6.
7
What is obesity? : Obesity Musings.什么是肥胖?:关于肥胖的思考。
Int J Obes (Lond). 2022 Jun;46(6):1081-1082. doi: 10.1038/s41366-022-01088-1. Epub 2022 Mar 14.
8
RET receptor signaling: Function in development, metabolic disease, and cancer.RET 受体信号转导:在发育、代谢疾病和癌症中的功能。
Proc Jpn Acad Ser B Phys Biol Sci. 2022;98(3):112-125. doi: 10.2183/pjab.98.008.
9
Clinical Characteristics, Surgical Management, and Prognostic Factors of Medullary Thyroid Carcinoma: A Retrospective, Single-Center Study.《甲状腺髓样癌的临床特征、外科治疗及预后因素:一项回顾性单中心研究》。
Technol Cancer Res Treat. 2022 Jan-Dec;21:15330338221078435. doi: 10.1177/15330338221078435.
10
Association of Obesity With Survival Outcomes in Patients With Cancer: A Systematic Review and Meta-analysis.肥胖与癌症患者生存结局的关联:系统评价和荟萃分析。
JAMA Netw Open. 2021 Mar 1;4(3):e213520. doi: 10.1001/jamanetworkopen.2021.3520.